Registration Dossier
Registration Dossier
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 211-745-8 | CAS number: 693-21-0
Endpoint summary
Administrative data
Link to relevant study record(s)
Description of key information
Short description of key information on bioaccumulation potential result:
Evaluation of toxicokinetics of the substance Diethyleneglycol dinitrate - CAS No. 693-21-0 was performed according to the demand given in part 8.8.1 of Annex VIII to the Directive (EC) No. 1907/2006 (REACH) : “Assessment of the toxicokinetic behavior of the substance to the extent that could be derived from the relevant available information”.
The evaluation of toxicokinetics is based on information from three sources:
- Experimental data of toxicological tests
- Literature data obtained from internet
- Data from toxicological databases – free and commercial
Key value for chemical safety assessment
- Bioaccumulation potential:
- no bioaccumulation potential
Additional information
The substance DEGDN is not absorbed through the skin. After oral or inhalation exposure it is fairly quickly absorbed and systemically distributed through the body (hours). Through the blood circulation it reaches and influences the heart, CNS, liver and kidneys, etc.
In the body the nitrate form is converted to nitrite form which causes the most of symptoms observed after exposition. It seems that the elimination through the kidneys to the urine takes several days after both the lower and higher doses.
Discussion on bioaccumulation potential result:
Probable Routes of Human Exposure
Occupational exposure to Diethylene glycol dinitrate may occur through dermal contact with this compound at workplaces where diethyleneglycol dinitrate is produced or used. Limited exposure to general population to diethyleneglycol dinitrate may occur via inhalation. In sporadic cases the acute oral poisoning is encountered.
Toxicokinetics Evaluation Summary
The substance is not absorbed through the skin. After oral or inhalation exposure it is fairly quickly absorbed and systemically distributed through the body (hours). Through the blood circulation it reaches and influences the heart, CNS, liver and kidneys, etc.
In the body the nitrate form is converted to nitrite form which causes the most of symptoms observed after exposition. It seems that the elimination through the kidneys to the urine takes several days after both the lower and higher doses.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
